Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-12-001717
Filing Date
2012-05-07
Accepted
2012-05-07 17:07:28
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_051012.htm 10-Q 650461
2 EXHIBIT 31.1 exh_311.htm EX-31.1 9224
3 EXHIBIT 31.2 exh_312.htm EX-31.2 8787
4 EXHIBIT 32.1 exh_321.htm EX-32.1 8150
  Complete submission text file 0001171843-12-001717.txt   2786518

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cbli-20120331.xml EX-101.INS 440815
6 XBRL TAXONOMY EXTENSION SCHEMA cbli-20120331.xsd EX-101.SCH 13816
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbli-20120331_cal.xml EX-101.CAL 28369
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbli-20120331_def.xml EX-101.DEF 83297
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbli-20120331_lab.xml EX-101.LAB 117429
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbli-20120331_pre.xml EX-101.PRE 86569
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

EIN.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32954 | Film No.: 12818648
SIC: 8731 Services-Commercial Physical & Biological Research